ROSSA took part in the congress and exhibition “Pharma Uzbekistan and Central Asia”, which took place in Tashkent from November 16 to 18, 2022. The event has become an important event for pharmaceutical manufacturers in Russia and Central Asia.

The Congress and exhibition “Pharma Uzbekistan and Central Asia” is a unique professional international platform for leaders of the pharmaceutical industry of Uzbekistan, Kazakhstan, Tajikistan and other countries with the participation of heads of investment projects, major enterprises, authorities, regulatory and supervisory authorities, licensors of production technologies, developers, manufacturers and suppliers of equipment, engineering and design and construction companies, technology and service providers. The event is dedicated to discussing the largest investment projects for the construction and modernization of production facilities, as well as opportunities to improve the efficiency of existing pharmaceutical manufacturing enterprises.

The congress raised issues of the development of drug production, innovative production technologies, improving the efficiency of factories and optimizing processes.

Within the framework of the program, the report “Strategies for the development of biomedical technologies – the experience of ROSSA” was delivered by ROSSA CEO Gaziev R.A..

On November 14, 2022, the Republican Intersectoral Industrial Exhibition organized by the Ministry of Investment and Foreign Trade of the Republic of Uzbekistan jointly with the Tashkent city Khokimiyat and the Center for Digital Transformation was held in Tashkent at the Uzexpocenter National Exhibition Center.

The purpose of the fair is to provide comprehensive support to local entrepreneurs and manufacturers, as well as to establish cooperative relations between them and pay special attention to the localization of products in high demand in the domestic market.

In order to further increase the industrial potential, stimulate the production of import-substituting products, expand localization, ROSSA presented a line of products of its own production at the last fair.

The set of reagents “MagSorb Plasma” is designed for the extraction of total RNA / DNA from blood plasma.

“ROSSAmed HBV-DNA” kit designed for qualitative detection of hepatitis B virus DNA by PCR with detection of results in “real time” mode. DNA samples isolated from blood plasma serve as the material for PCR.

“ROSSAmed HCV”  kit designed for qualitative detection of hepatitis C virus.